Pharmaceutical Product Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:North America

Author(s):

Product Code:GDPH32194D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

November 2018

Total pages

64

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

Pharmaceutical Product Development LLC (PPD) is a contract research organization (CRO), which offers drug discovery, development and lifecycle management services. The company's service portfolio encompasses early development clinical trial services, drug research and development, regulatory support and late-stage clinical trial management, among others. It has expertise in clinical trials in therapy areas including cardiovascular system, central nervous system, dermatology, gastroenterology, hematology, cancer, infectious diseases, ophthalmology, respiratory and endocrine systems, metabolism, rare diseases and urology. PPD's clients include pharmaceutical, biotechnology, medical device, and academic and government organizations. The company has a presence in North America, South America, Europe, Middle East, Africa, and Asia-Pacific. PPD is headquartered in Wilmington, North Carolina, the US.

Pharmaceutical Product Development LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Pharmaceutical Product Development LLC, Medical Devices Deals, 2012 to YTD 2018 11

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deal Details 14

Asset Purchase 14

Pharmaceutical Product Development Acquires Sequential Parallel Comparison Design from RCT Logic 14

Partnerships 15

Pharma Product Development Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15

BioDuro Enters into Agreement with Pfizer 16

BioDuro Enters into Agreement with Porton Pharma Solutions 17

Pharmaceutical Product Development Enters into Agreement with Quotient Sciences 18

Treos Bio Enters into Agreement with Pharmaceutical Product Development 19

Pharmaceutical Product Development Enters into Agreement with Frenova Renal Research 20

Moderna Therapeutics Enters into Agreement with Pharmaceutical Product Development 21

Pharma Product Development Enters into Contract Agreement with USAMMDA and USAMRMC 22

Pharma Product Development Enters into Agreement with BARDA 23

Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 24

BioAtla Enters into Co-Development Agreement with BioDuro 25

Boston Strategics Enters into Agreement with Molecular Response 26

Pharmaceutical Product Development and X-Chem Form Joint Venture 27

Molecular Response Enters Into Co-Development Agreement With OncoMed Pharma 28

Pharma Product Development Expands Co-Development Agreement With VirtualScopics 29

Debt Offering 30

Jaguar Holding Company II and Pharmaceutical Product Development to Raise USD1,125 Million in Private Placement of Notes 30

Pharmaceutical Product Development Announces Public Offering Of Notes For USD 500 Million 31

Asset Transactions 32

Crown Bioscience Acquires PDX Business Unit from Molecular Response 32

Acquisition 33

LabCorp May Acquire Pharmaceutical Product Development 33

Pharmaceutical Product Development Acquires Evidera 34

BioDuro Acquires Formex 35

Pharmaceutical Product Development Exercises Option to Acquire Remaining 36% Stake in X-Chem 36

Pharmaceutical Product Development Acquires Acurian, Patient Recruitment Company 37

Pharmaceutical Product Development LLC-Key Competitors 38

Pharmaceutical Product Development LLC-Key Employees 39

Pharmaceutical Product Development LLC-Locations And Subsidiaries 40

Head Office 40

Other Locations & Subsidiaries 40

Joint Venture 43

Recent Developments 44

Strategy And Business Planning 44

Mar 28, 2018: PPD Expands GMP Biologics Testing Capacity 44

May 18, 2017: PPD Expands Vaccine Development Laboratory 45

Feb 28, 2017: PPD Introduces Rare Disease and Pediatric Center of Excellence 46

Jan 30, 2017: PPD to Open New Clinical Research Unit in Las Vegas 47

Corporate Communications 48

Sep 18, 2018: PPD focused on employee well-being providing uninterrupted client service after Hurricane 48

Jul 24, 2018: PPD Names Ron Garrow as Chief Human Resource Officer 49

May 04, 2018: Christopher Scully Joins PPD as Chief Financial Officer 50

Feb 01, 2018: Pharmaceutical Product Development Appoints Maria Teresa Hilado As Board Director 51

Jan 03, 2018: PPD Names Colin Hill, CEO of GNS Healthcare, to its Board of Directors 52

Government and Public Interest 53

Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 53

Feb 21, 2018: PPD Recognized for Superior Employee Development 55

Mar 02, 2017: PPD Awarded National Institutes of Health Contract for HIV Research Support 56

Product News 57

Jun 25, 2018: PPD's PatientAdvantage Inverts Traditional Clinical Trial Delivery Method 57

Other Significant Developments 58

Jul 25, 2018: PPD Expands Central Labs' Preclarus technology, helping clients accelerate and enhance clinical research decision making 58

Apr 23, 2018: Acurian and Synexus Launch NASH Patient Enrollment Solution 59

Feb 28, 2018: PPD and Acurian Introduce Innovative Patient Concierge Service for Clinical Trials 60

Oct 24, 2017: Evidera Expands Patient-Centered Research Services 61

May 08, 2017: PPD Creates Dedicated Real-world Research and Market Access Unit by Combining Medical Affairs Research Operations and Evidera 62

Mar 23, 2017: PPD Announces Industry-First Apprenticeship for Clinical Research Associates 63

Appendix 64

Methodology 64

About GlobalData 64

Contact Us 64

Disclaimer 64


List of Figure

List of Figures

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Pharmaceutical Product Development LLC, Medical Devices Deals, 2012 to YTD 2018 11


List of Table

List of Tables

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Key Facts 2

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Pharmaceutical Product Development LLC, Deals By Therapy Area, 2012 to YTD 2018 9

Pharmaceutical Product Development LLC, Medical Devices Deals, 2012 to YTD 2018 11

Pharmaceutical Product Development LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Pharmaceutical Product Development Acquires Sequential Parallel Comparison Design from RCT Logic 14

Pharma Product Development Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15

BioDuro Enters into Agreement with Pfizer 16

BioDuro Enters into Agreement with Porton Pharma Solutions 17

Pharmaceutical Product Development Enters into Agreement with Quotient Sciences 18

Treos Bio Enters into Agreement with Pharmaceutical Product Development 19

Pharmaceutical Product Development Enters into Agreement with Frenova Renal Research 20

Moderna Therapeutics Enters into Agreement with Pharmaceutical Product Development 21

Pharma Product Development Enters into Contract Agreement with USAMMDA and USAMRMC 22

Pharma Product Development Enters into Agreement with BARDA 23

Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical 24

BioAtla Enters into Co-Development Agreement with BioDuro 25

Boston Strategics Enters into Agreement with Molecular Response 26

Pharmaceutical Product Development and X-Chem Form Joint Venture 27

Molecular Response Enters Into Co-Development Agreement With OncoMed Pharma 28

Pharma Product Development Expands Co-Development Agreement With VirtualScopics 29

Jaguar Holding Company II and Pharmaceutical Product Development to Raise USD1,125 Million in Private Placement of Notes 30

Pharmaceutical Product Development Announces Public Offering Of Notes For USD 500 Million 31

Crown Bioscience Acquires PDX Business Unit from Molecular Response 32

LabCorp May Acquire Pharmaceutical Product Development 33

Pharmaceutical Product Development Acquires Evidera 34

BioDuro Acquires Formex 35

Pharmaceutical Product Development Exercises Option to Acquire Remaining 36% Stake in X-Chem 36

Pharmaceutical Product Development Acquires Acurian, Patient Recruitment Company 37

Pharmaceutical Product Development LLC, Key Competitors 38

Pharmaceutical Product Development LLC, Key Employees 39

Pharmaceutical Product Development LLC, Other Locations 40

Pharmaceutical Product Development LLC, Subsidiaries 42

Pharmaceutical Product Development LLC, Joint Venture 43

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022